Evidence map›Paper›PMID 30714674›Full record

ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2019

Robust Cell Detection and Segmentation for Image Cytometry Reveal Th17 Cell Heterogeneity.

Takahiro Tsujikawa, Guillaume Thibault, Vahid Azimi, Sam Sivagnanam, Grace Banik, Casey Means, Rie Kawashima, Daniel R Clayburgh, Joe W Gray, Lisa M Coussens and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 2 countries.

Takahiro TsujikawaDepartment of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, Oregon, USA.
Guillaume ThibaultDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, USA.
Vahid AzimiComputational Biology Program, Oregon Health & Science University, Portland, Oregon, USA.
Sam SivagnanamComputational Biology Program, Oregon Health & Science University, Portland, Oregon, USA.
Grace BanikDepartment of Otolaryngology-Head & Neck Surgery, Oregon Health & Science University, Portland, Oregon, USA.
Casey MeansDepartment of Otolaryngology-Head & Neck Surgery, Oregon Health & Science University, Portland, Oregon, USA.
Rie KawashimaDepartment of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, Oregon, USA.
Daniel R ClayburghDepartment of Otolaryngology-Head & Neck Surgery, Oregon Health & Science University, Portland, Oregon, USA.
Joe W GrayDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, USA.
Lisa M CoussensDepartment of Cell, Developmental, and Cancer Biology, Oregon Health & Science University, Portland, Oregon, USA.
Young Hwan ChangDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, USA.ORCID 0000-0001-8764-1959
Oregon Health & Science University · US

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Grace B Gill · 1997 to 2026
$60.5M
Oregon Clinical and Translational Research InstituteUL1TR000128 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLISON, DAVID H · 2012 to 2015
$28.7M
Understanding the Impact of Microscale and Nanoscale Heterogeneity and ResistanceU54CA209988 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GRAY, JOE W. · 2017 to 2021
$10.3M
Omic and Multidimensional Spatial Atlas of Metastatic Breast CancerU2CCA233280 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOECKS, JEREMY · 2018 to 2023
$9.7M
NCATS NIH HHS UL1 TR000128NCI NIH HHS P30 CA069533NCI NIH HHS U54 CA209988
6 · The paper itself

Abstract

Image cytometry enables quantitative cell characterization with preserved tissue architecture; thus, it has been highlighted in the advancement of multiplex immunohistochemistry (IHC) and digital image analysis in the context of immune-based biomarker monitoring associated with cancer immunotherapy. However, one of the challenges in the current image cytometry methodology is a technical limitation in the segmentation of nuclei and cellular components particularly in heterogeneously stained cancer tissue images. To improve the detection and specificity of single-cell segmentation in hematoxylin-stained images (which can be utilized for recently reported 12-biomarker chromogenic sequential multiplex IHC), we adapted a segmentation algorithm previously developed for hematoxlin and eosin-stained images, where morphological features are extracted based on Gabor-filtering, followed by stacking of image pixels into n-dimensional feature space and unsupervised clustering of individual pixels. Our proposed method showed improved sensitivity and specificity in comparison with standard segmentation methods. Replacing previously proposed methods with our method in multiplex IHC/image cytometry analysis, we observed higher detection of cell lineages including relatively rare T

Indexed as

AlgorithmsCarcinoma, Pancreatic DuctalCell NucleusDiagnosis, DifferentialHead and Neck NeoplasmsHematoxylinHumansImage CytometryImage Interpretation, Computer-AssistedImmunohistochemistryLung NeoplasmsMesotheliomaMesothelioma, MalignantPancreatic NeoplasmsPleural NeoplasmsPrognosisHematoxylincell segmentationTH17 cell phenotypestumor immune microenvironment

Identifiers

PMID30714674
PMCPMC6461524
OpenAlexW2911830042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.